Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese registry of intravenous thrombolysis for acute ischemic stroke
ChiCTR-OPC-17013788Phase 4Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jan 2018
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of urokinase and tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: modified Rankin Scale. Started Jan 2018; status: recruiting.
02
Drugs
urokinasetissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-OPC-17013788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17013788.